What is the management of proctitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Proctitis

The initial treatment for proctitis should be ceftriaxone 250 mg IM in a single dose PLUS doxycycline 100 mg orally twice a day for 7 days while awaiting diagnostic test results, as this addresses the most common infectious causes and reduces morbidity and mortality. 1

Diagnostic Approach

  • Perform anoscopic examination to visualize rectal mucosa and identify:

    • Presence of anorectal exudate
    • Mucosal ulcerations
    • Perianal lesions
    • Signs of inflammation
  • Obtain laboratory testing for common infectious causes:

    • Neisseria gonorrhoeae (NAAT and culture)
    • Chlamydia trachomatis (NAAT)
    • Herpes Simplex Virus (PCR)
    • Syphilis serology
    • HIV testing (mandatory for all patients with proctitis) 1, 2
    • Consider testing for Mycoplasma genitalium 2

Treatment Algorithm

1. Infectious Proctitis

Empiric Treatment

  • Start empiric therapy if any of the following are present:

    • Anorectal exudate
    • Polymorphonuclear leukocytes on Gram stain
    • Clinical presentation consistent with acute proctitis 1
  • First-line empiric regimen:

    • Ceftriaxone 250 mg IM single dose PLUS
    • Doxycycline 100 mg orally twice daily for 7 days 1

Specific Pathogen Management

  • For suspected LGV (bloody discharge, perianal ulcers, mucosal ulcers with positive rectal chlamydia NAAT or HIV infection):

    • Extend doxycycline treatment to 3 weeks total 1
  • For suspected/confirmed HSV (painful perianal ulcers):

    • Add one of the following:
      • Acyclovir
      • Valacyclovir
      • Famciclovir 1

2. Inflammatory Proctitis (e.g., Ulcerative Proctitis)

  • First-line treatment:

    • Mesalamine (5-ASA) suppository 1g once daily 1
  • For inadequate response:

    • Combine topical mesalamine with oral mesalamine OR
    • Combine topical mesalamine with topical steroids 1
  • For refractory disease:

    • Consider IV steroid therapy
    • Alternative topical therapies
    • Surgical options in severe cases 1

Partner Management and Follow-up

  • Sexual partners from past 60 days should be:

    • Evaluated
    • Tested
    • Treated presumptively 1
  • Both patient and partners should abstain from sexual intercourse until:

    • Treatment completion
    • Symptom resolution 1
  • Follow-up testing:

    • Retest for gonorrhea or chlamydia 3 months after treatment 1

Important Clinical Considerations

  • Multiple pathogens may be present simultaneously, necessitating comprehensive testing 1, 3

  • Suppositories are preferred over enemas for proctitis as they:

    • Deliver medication more effectively to the rectum
    • Are better tolerated by patients 1
  • Address proximal constipation if present, as it can affect drug delivery in distal colitis 1

  • The incidence of infectious proctitis is rising, especially in men who have sex with men 3

  • Symptoms of proctitis can overlap between infectious and inflammatory causes, including:

    • Rectal bleeding
    • Mucous discharge
    • Anorectal pain
    • Tenesmus
    • Diarrhea or constipation 3, 4
  • Herpes proctitis can be particularly severe in patients with HIV 1

  • Distinguishing between infectious proctitis and inflammatory bowel disease is crucial for appropriate management 1, 5

References

Guideline

Proctitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Proctitis: An Approach to the Symptomatic Patient.

The Medical clinics of North America, 2024

Research

Diagnosis and treatment of ulcerative proctitis.

Journal of clinical gastroenterology, 2004

Research

Infectious proctitis: a necessary differential diagnosis in ulcerative colitis.

International journal of colorectal disease, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.